Drugs that contain Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate
1. Drug name - OSMOPREP
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7687075 | SALIX PHARMS | Colonic purgative composition with soluble binding agent |
Jun, 2028
(5 years from now) | |
| CN101087593B | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| CN101087593A | SALIX PHARMS | Colon Cathartic Constituent Containing Dissoluble Adhesive |
Nov, 2024
(2 years from now) | |
| CN102648980A | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| CN102648980B | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| EP1682098A1 | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| EP2308476A1 | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| EP2308476B1 | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
| EP1682098B1 | SALIX PHARMS | Colonic Purgative Composition With Soluble Binding Agent |
Nov, 2024
(2 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.398GM;1.102GM | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.